IMPROVED PATIENT AND GRAFT SURVIVAL AFTER TREATMENT OF ACUTE REJECTIONS OF CADAVERIC RENAL ALLOGRAFTS WITH RABBIT ANTITHYMOCYTE GLOBULIN